Commodore Capital LP 13D/13G Filings for Nurix Therapeutics, Inc. (NRIX)

Commodore Capital LP 13D and 13G filings for Nurix Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-14
5:02 pm
Sale
2025-09-3013GNurix Therapeutics, Inc.
NRIX
Commodore Capital LP3,780,055
4.900%
-69,945decrease
(-1.82%)
Filing
2025-02-14
4:05 pm
Purchase
2025-02-0713GNurix Therapeutics, Inc.
NRIX
Commodore Capital LP3,850,000
5.100%
3,850,000increase
(New Position)
Filing